New role for gene that counteracts formation of tumorsAugust 26, 2005Ghent-Scientists from the Flanders Interuniversity Institute for Biotechnology (VIB) have achieved a new breakthrough in cancer research. The researchers, connected to Ghent University, have discovered the function of an important mediator involved in suppressing the development of tumors. Using a mouse model, they have shown that absence of the mediator makes the mice susceptible to the development of cancer. Through this research, the scientists are contributing to a better understanding of the molecular mechanisms that control tumor development. Cell cycle: a vital, controlled process in our body Every day, the billions of cells that compose our body are being replaced: old cells die and new ones are produced. In the course of this process, each cell goes through a well-organized series of phases. First of all, the hereditary material, or DNA, in the cell nucleus is duplicated. Next, the nucleus divides itself in half; and then the entire cell divides, and the daughter cells grow into completely new cells. Because it is crucial that this cell cycle runs perfectly, various control points have been built in to enable the cell to control the stability of the DNA. If the DNA becomes damaged, the cell cycle will come to a stop.
A central role for the p53 protein in cancer The p53 protein is responsible for stopping the cell cycle. Normally, this happens at the end of the growth phase-but, if the DNA has been damaged or if other problems arise, p53 can also trigger programmed cell death. Because p53 can halt the further growth of cells, this protein plays an essential role in suppressing the development of tumors and blocking the onset of cancer. When cancer appears, the p53 protein is deactivated-either through an alteration or mutation in the gene itself, or through modified activity of the proteins that regulate p53 or that influence its activity. Ptprv, a new target for p53 Research by Gilles Doumont, Alain Martoriati and their colleagues from the team of Jean-Christophe Marine has revealed that the protein Ptprv works with p53. In certain circumstances, p53 directly influences the production of Ptprv. In the case of DNA damage, Ptprv turns out to play a key role in stopping the cell cycle and also contributes to blocking the development of tumors. This important role for Ptprv has been demonstrated using mouse models. Although the Ghent researchers have elucidated its role in the development of cancer, the actual function of Ptprv has not yet been discovered. Does Ptprv open new perspectives for the treatment of cancer? After exposure to carcinogens, mice that lack Ptprv develop cancer much more readily than normal mice do. The findings of the Ghent researchers show that Ptprv is an essential player in preventing and counteracting cancer. Further research can reveal whether Ptprv can be a potential point of action for the treatment of cancer. VIB, Flanders Interuniversity Institute of Biotech | |||||||||||||||||||||
|
Related Tumors Current Events and Tumors News Articles Genetic breakdown in Fanconi anemia may have link to HPV-associated cancer A genetic malfunction that causes DNA instability in people with the blood disorder Fanconi anemia may put them at high risk for squamous cell carcinomas linked to human papillomavirus (HPV), according to a study posted online ahead of print by Oncogene. Researchers Discover New Enzyme in Cancer Growth While studying the mechanics of blood clots, researchers at the University of Oklahoma Health Sciences Center discovered a new enzyme that not only affects the blood, but seems to play a primary role in how cancer tumors expand and spread throughout the body. EEGs show brain differences between poor and rich kids University of California, Berkeley, researchers have shown for the first time that the brains of low-income children function differently from the brains of high-income kids. Dancing atoms now understood In developing a model to explain the motion of atoms in a magnetic field, scientists have overcome a decades-old obstacle to understanding a key component of magnetic resonance. New statistical model could help reduce breast-lesion biopsies A new method of characterizing breast lesions found during an MRI exam could result in fewer biopsies of benign tumors with the benefits of reduced pain and expense for patients and providers, according to a paper that will be presented today (Sunday, Nov. 30) at the annual meeting of the Radiological Society of North America (RSNA). Combining targeted therapy drugs may treat previously resistant tumors A team of cancer researchers from several Boston academic medical centers has discovered a potential treatment for a group of tumors that have resisted previous targeted therapy approaches. Prostate cancer spurs new nerves Prostate cancer - and perhaps other cancers - promotes the growth of new nerves and the branching axons that carry their messages, a finding associated with more aggressive tumors, said researchers from Baylor College of Medicine in the first report of the phenomenon that appears today in the journal Clinical Cancer Research. Breast cancer treatment offers better outcome to women with implants Women with early-stage breast cancer who have undergone breast augmentation may be treated successfully with a partial-breast radiation treatment called brachytherapy, according to a study presented today at the annual meeting of the Radiological Society of North America (RSNA). Study unmasks how ovarian tumors evade immune system Scientists at Johns Hopkins have determined how the characteristic shedding of fatty substances, or lipids, by ovarian tumors allows the cancer to evade the body's immune system, leaving the disease to spread unchecked Studies show novel device may enhance chemotherapy treatment in brain tumors NovoCure Ltd. presented results yesterday evaluating the Novo-TTF device in vitro and in a pilot clinical trial that showed the device enhanced the efficacy of standard chemotherapy (temozolomide) treatment in newly-diagnosed glioblastoma multiforme (GBM) patients. More Tumors Current Events and Tumors News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||